In orthotopic mouse models of hepatocellular carcinoma (HCC), the IV injection of EVs-miR-199a loaded by the lentivirus transfection of adipose-tissue derived MSCs improved HCC chemosensitivity to doxorubicin via mTOR pathway targeting [123]. Here, MTOR is linked to hepatocellular carcinoma.